corporate information


	Corporate Information

Officers

C. William Zadel
Chairman, President and
Chief Executive Officer

Francis J. Lunger
Executive Vice President,
Chief Operating Officer

Kathleen B. Allen
Vice President, Chief Financial Officer
and Treasurer

Michael P. Carroll
Vice President

J. Edward Lary
Vice President

Joanna M. Nikka
Vice President

Jeffrey Rudin
Vice President and Clerk,
General Counsel

Hideo Takahashi
Vice President

Directors

C. William Zadel
Chairman, President and
Chief Executive Officer

Professor Dr. Daniel Bellus ²
University of Fribourg, Switzerland
(Elected as Director, March 10, 2000)

Robert C. Bishop, Ph.D. ²
Chairman of the Board
AutoImmune, Inc.,
Lexington, Massachusetts

Samuel C. Butler ²
Partner
Cravath, Swaine & Moore,
New York, New York
(Retired as Director, March 10, 2000)

Robert E. Caldwell ²
Retired Vice President and
General Manager
Digital Semiconductor Division
Digital Equipment Corporation,
Hudson, Massachusetts

Elaine L. Chao ³
Distinguished Fellow
The Heritage Foundation,
Washington, D.C.

Maureen A. Hendricks ¹
Managing Director
Salomon Smith Barney, Inc.,
New York, New York

Richard J. Lane ¹
President, Worldwide Medicines
Bristol-Myers Squibb Company,
Plainsboro, New Jersey

Mark Hoffman ¹
Independent Investor and Consultant

Thomas O. Pyle ³
Independent Business Advisor and Corporate Director of Healthcare Organizations

John F. Reno ³
Retired Chairman, President and
Chief Executive Officer
Dynatech Corporation,
Burlington, Massachusetts

Corporate Offices

Millipore Corporation
80 Ashby Road
Bedford, Massachusetts 01730-2271
Tel: (781) 533-6000
Fax: (781) 533-3110
Internet: www.millipore.com

¹ Member of the Audit and Finance Committee

² Member of the Management Development and Compensation Committee

³ Member of the Governance and Public Policy Committee

Millipore, Microcon, MicroFil, MultiScreen, Viresolve, Prosep, QuickChange and AdapTorr are registered trademarks of Millipore or an affiliated company.

Intelliflow, ZipTip, Immobilon, MicroStar, Hi-Flow, Millistak, AFS, Direct-Q, Thermogard, Rinsegard, Solaris, Chemgard, Chambergard, SolidSense and SureView are trademarks of Millipore Corporation or an affiliated company. CIO is a trademark of International Data Group, Inc.

Subsidiaries and Offices

Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Holland
Hong Kong
Hungary
India
Ireland
Italy
Japan
Korea
Malaysia
Mexico
Norway
Poland
Puerto Rico
Russia
Singapore
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States

Manufacturing Sites

Brazil
China
France
Ireland
Japan
Puerto Rico
United Kingdom
United States

The matters discussed herein, as well as in future oral and written statements by management of the Company, that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Potential risks and uncertainties that could affect the Company’s future operating results include, without limitation, foreign exchange rates; increased regulatory concerns on the part of the biopharmaceutical industry; further consolidation of drug manufacturers; competitive factors such as new membrane technology, and/or a new method of chip manufacture which relies less heavily on purified chemicals and gases; availability of raw materials or component products on a timely basis; inventory risks due to shifts in market demand; change in product mix; conditions in the economy in general, and in the microelectronics manufacturing market in particular; potential environmental liabilities; the inability to utilize technology in current or planned products due to overriding rights by third parties, and the risk factors listed from time to time in the Company’s filings with the SEC.